Navigation Links
Bird Repellent Gains Approval by Virginia

NEW CASTLE, Del., April 6, 2011 /PRNewswire/ -- In some areas of Virginia, blackbirds are causing moderate to severe crop damage.  In an effort to combat the problem, the state has issued a Section 18 exemption to the standard label requirements for the 2011 planting season.  This allows farmers to use Avipel® Crop Seed Treatment to protect their field and sweet corn seed.

The problem of bird damage to crops is not unique to this state, and it is growing.  The Virginia exemption focuses on blackbirds; however, in other states, cranes and pheasants have been cited as the "problem" species.  Due to habitat restoration and other environmental efforts, bird populations have been on the rebound in recent years.  More birds result in more damage to newly planted fields.  This is because many species find corn seed to be an attractive food source, and a large flock can cause damage so severe that fields need to be replanted.

Coating seeds with Avipel® has a negative impact on digestion.  After initially sampling the treated seed, birds avoid it and look for other food sources.  Using Avipel® products offers farmers an effective and humane solution to crop damage caused by foraging birds.  Plus, it saves the time and money involved in having to replant damaged fields.  Information about approved uses and labels may be found at:

Arkion Life Sciences is a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies.  In addition to Avipel® for crop protection, Arkion's patented formulations of anthraquinone effectively repel geese from turf grass with FlightControl® Plus and birds from structures using Airepel® Service Blend.

Arkion Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical compounds.  Arkion has three major businesses: Airepel®, supplying bird repellents which feature non-lethal methods to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which provides contract services for development of microbial fermentation processes such as glucosamine, N-acetylglucosamine and natamycin.

SOURCE Arkion Life Sciences LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AV-1011 Bird Repellent to Protect Rice Seed Approved for Use in Louisiana and Missouri
2. Discovery of natural odors could help develop mosquito repellents
3. Arkion Bird Repellent Approved for Use in Three Southern States
4. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
5. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
6. Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
7. UCF professor develops vaccine to protect against black plague bioterror attack
8. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
9. Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
10. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
11. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
Post Your Comments:
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" ... , President and Chief Executive Officer of ProMetic, will be ... th Annual Healthcare Conference to be held at the ... st , at 8.50am (ET) and ProMetic,s management team ... presentation will be available live via a webcast accessible at ...
(Date:11/24/2015)... 2015 HemoShear Therapeutics, LLC, a privately ... metabolic disorders, announced today the appointment of ... Directors (BOD). Mr. Watkins is the former president ... (HGS), and also served as the chairman of ... , Chairman and CEO of HemoShear Therapeutics. "The ...
(Date:11/24/2015)... YORK , November 24, 2015 ... in a European healthcare ... which the companies will work closely together in identifying European ... unmet medical need. The collaboration is underpinned by a significant ... fund. This is the first investment by Bristol-Myers Squibb in ...
Breaking Biology Technology:
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
Breaking Biology News(10 mins):